当前位置:首页 - 行情中心 - 金陵药业(000919) - 财务分析 - 资产负债表

金陵药业

(000919)

  

流通市值:42.21亿  总市值:44.60亿
流通股本:5.90亿   总股本:6.24亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金1,254,484,540.881,355,659,403.851,817,309,724.191,429,692,592.58
应收票据及应收账款747,662,546.04648,310,164.91658,333,210.61519,573,774.77
其中:应收票据207,040,765.34167,096,871.81164,828,702.66201,700,040.68
应收账款540,621,780.7481,213,293.1493,504,507.95317,873,734.09
预付款项19,861,369.1512,827,591.6319,803,238.287,183,132.94
其他应收款合计9,031,224.789,391,271.728,277,389.285,668,040.16
存货248,069,135.45244,205,920.06252,393,007.71268,060,352.54
一年内到期的非流动资产10,000,00010,000,000--
其他流动资产8,702,843.337,802,723.638,119,874.644,810,601.31
流动资产平衡项目0000
流动资产合计3,149,840,677.793,083,477,655.373,117,124,652.912,317,556,462.2
非流动资产:
长期股权投资253,729,611.24249,637,763.39268,133,125.09269,896,381.09
其他权益工具投资1,013,253.081,013,253.081,013,253.081,146,563.08
投资性房地产7,681,145.217,919,474.698,157,804.178,396,133.65
固定资产1,279,445,063.911,298,800,055.661,290,462,228.581,297,455,495.99
在建工程28,010,980.9225,583,445.7121,410,061.2916,489,741.66
生产性生物资产1,172,255.121,228,107.741,283,960.361,339,812.98
使用权资产3,915,143.754,362,882.94,871,746.295,343,317.04
无形资产255,797,658.14259,971,038.09263,512,236.71266,973,459.9
开发支出3,498,113.21---
商誉27,331,541.7927,331,541.7927,331,541.7927,331,541.79
长期待摊费用11,401,344.5610,567,739.6611,996,833.713,941,249.35
递延所得税资产-8,291,470.0713,803,010.611,050,160.77
其他非流动资产333,012,502.87324,039,023.23313,913,248.82313,602,527.48
非流动资产平衡项目0000
非流动资产合计2,206,008,613.82,218,745,796.012,225,889,050.482,232,966,384.78
资产平衡项目0000
资产总计5,355,849,291.595,302,223,451.385,343,013,703.394,550,522,846.98
流动负债:
应付票据及应付账款511,607,662.63488,827,053.45483,092,619.87431,597,570.58
其中:应付票据47,159,118.4244,816,133.1141,166,311.0146,308,292.73
应付账款464,448,544.21444,010,920.34441,926,308.86385,289,277.85
预收款项1,259,270.51,918,089.42,453,094.942,361,303.55
合同负债24,424,601.8221,558,763.2316,352,616.3313,856,337.46
应付职工薪酬88,115,710.8389,177,011.7570,095,963.17118,143,672.2
应交税费38,213,193.9944,877,521.4449,694,633.4930,058,121.48
其他应付款合计228,792,461.91205,130,989.61212,435,370.01240,721,154.75
一年内到期的非流动负债2,306,469.242,614,744.62329,170.122,265,295.36
其他流动负债1,891,613.551,151,563.411,170,503.07894,956.99
流动负债平衡项目0000
流动负债合计896,610,984.47855,255,736.91835,623,971839,898,412.37
非流动负债:
租赁负债1,515,966.561,870,066.724,503,101.932,549,427.63
递延收益387,807.27387,807.27440,956.63467,531.31
递延所得税负债19,831,751.9122,994,218.128,130,461.8122,661,808.96
非流动负债平衡项目0000
非流动负债合计21,735,525.7425,252,092.0933,074,520.3725,678,767.9
负债平衡项目0000
负债合计918,346,510.21880,507,829868,698,491.37865,577,180.27
所有者权益(或股东权益):
实收资本(或股本)629,060,528629,060,528629,060,528511,136,000
资本公积1,105,691,414.841,105,691,414.841,105,691,414.84480,983,653.51
减:库存股26,994,24026,994,24026,994,24026,994,240
其他综合收益2,551,457.022,512,226.612,512,226.612,512,226.61
专项储备916,877.51951,921.22481,649.65911,706.68
盈余公积408,647,578.17408,647,578.17408,647,578.17408,647,578.17
未分配利润1,674,591,243.631,655,041,385.61,708,959,770.881,665,415,042.13
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计3,794,464,859.173,774,910,814.443,828,358,928.153,042,611,967.1
少数股东权益643,037,922.21646,804,807.94645,956,283.87642,333,699.61
股东权益平衡项目0000
股东权益合计4,437,502,781.384,421,715,622.384,474,315,212.023,684,945,666.71
负债和股东权益合计5,355,849,291.595,302,223,451.385,343,013,703.394,550,522,846.98
公告日期2024-10-292024-08-272024-04-302024-04-30
审计意见(境内)标准无保留意见
TOP↑